Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • Medical Jobs
  • Medical Matrimony
  • MD Brand Connect
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • MCI News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Aborad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • MCI News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • SGLT2 inhibitor

Tag: SGLT2 inhibitor

You Searched For "SGLT2 inhibitor"
Empagliflozin may decrease risk of kidney stones in people with diabetes

Empagliflozin may decrease risk of kidney stones in people with diabetes

Dr. Kamal Kant Kohli15 Jun 2022 3:45 AM GMT
The diabetes drug empagliflozin may decrease the risk of kidney stones in patients with type 2 diabetes, according to a new study presented Sunday,...
Empagliflozin improves cognitive impairment in frail diabetics with HFpEF: Study

Empagliflozin improves cognitive impairment in frail diabetics with HFpEF: Study

Medha Baranwal1 April 2022 5:15 AM GMT
Italy: SGLT2 inhibitor empagliflozin improves cognitive and physical impairment in frail older adults with type 2 diabetes and heart failure with...
28/February/2022 Top Medical Bulletin

28/February/2022 Top Medical Bulletin

Dr. Nandita Mohan28 Feb 2022 1:15 PM GMT
Here are top medical stories for todayGlucose Variability During Early Course Of Acute Pancreatitis Can Predict New-Onset Of Diabetes Diabetes is a...
25/February/2022 Top Medical Bulletin

25/February/2022 Top Medical Bulletin

Dr. Nandita Mohan25 Feb 2022 1:21 PM GMT
Here are today's top medical stories Is French fried potato consumption Related to Adverse Health Outcomes?Fries is a most consumed junk food all...
SGLT2 inhibitor dapagliflozin may prevent cardiovascular complications in type 1 diabetes: Study

SGLT2 inhibitor dapagliflozin may prevent cardiovascular complications in type 1 diabetes: Study

Medha Baranwal23 Feb 2022 4:15 AM GMT
Budapest, Hungary: Recent data published in PLOS One supports the preventive and protective role of SGLT2 inhibitors in cardiovascular disease (CVD)...
SGLT2 inhibitor empagliflozin may improve brains insulin sensitivity in prediabetics: Study

SGLT2 inhibitor empagliflozin may improve brain's insulin sensitivity in prediabetics: Study

Medha Baranwal28 Dec 2021 4:30 AM GMT
Germany: Researchers in a recent study published in Diabetes Care have shown for the first time that the SGLT2 inhibitor empagliflozin can be used for...
Pharmacological Treatment of Diabetes: ADA 2022 explores beyond metformin as initial therapy

Pharmacological Treatment of Diabetes: ADA 2022 explores beyond metformin as initial therapy

Dr. Prem Aggarwal24 Dec 2021 10:30 AM GMT
New Delhi: Metformin has been the cornerstone of Diabetes management for a long time. However, with the growing research in the field of diabetes and...
Empagliflozin retains benefits in True HFpEF Patients

Empagliflozin retains benefits in 'True' HFpEF Patients

Ruchika Sharma3 Dec 2021 12:01 PM GMT
Empagliflozin provides a wide range of benefits in patients with "true" heart failure and preserved ejection fraction (HFpEF) , meaning an LVEF of 50%...
Reluctance in SGLT-2 inhibitors usage

Reluctance in SGLT-2 inhibitors usage

Dr Umesh Khanna6 Oct 2021 10:46 AM GMT
Understanding the reluctance in using SGLT2 inhibitors as drug of choice despite of its cardioprotective and renoprotective properties
Dapagliflozin relieves symptoms, physical limitations in HFpEF patients: PRESERVED-HF trial

Dapagliflozin relieves symptoms, physical limitations in HFpEF patients: PRESERVED-HF trial

Medha Baranwal25 Sep 2021 3:30 AM GMT
USA: Dapagliflozin improves physical limitations and symptoms in patients having heart failure with preserved ejection fraction (HFpEF) within a...
SGLT-2 Inhibitors Increase Retinal Vein Occlusion Risk in Diabetics, Study Finds

SGLT-2 Inhibitors Increase Retinal Vein Occlusion Risk in Diabetics, Study Finds

MD Bureau16 July 2021 3:30 AM GMT
SGLT2 inhibitors are associated with an increased risk of RVO when compared with other glucose lowering drugs.
SGLT-2 Inhibitors may Improve Endothelial Function in T2D with CVD: Study

SGLT-2 Inhibitors may Improve Endothelial Function in T2D with CVD: Study

Dr Kartikeya Kohli2 July 2021 3:30 AM GMT
Empagliflozin treatment has potential to improve endothelial function and has cardiovascular benefits, finds new study.
Next

Editorial

Journal Club Today

Health News Today

© 2022 All Rights Reserved.
Powered By: Hocalwire
X
X